<DOC>
	<DOCNO>NCT00128401</DOCNO>
	<brief_summary>This study examine whether antibiotic , d-cycloserine ( DCS ) , boost effectiveness cognitive behavior therapy ( CBT ) social anxiety . CBT show effective treatment social anxiety child adult , even treatment , approximately 40 % may remain diagnosable . The antibiotic DCS show enhance type learning promote exposure therapy , main component CBT . This study test whether DCS improve effectiveness CBT social anxiety . All participant receive 12 weekly CBT session . In addition receiving CBT , participant randomly assign ( similar coin toss ) receive either DCS placebo ( sugar pill ) . The pill take 1-2 hour prior 12 CBT session . The pill take 12 therapy day . Prior receive treatment , participant ask : - participate interview assess diagnosis include mood , degree nervousness behavior - physical examination , urine test , electrocardiogram ( EKG ) - undergo test involve problem-solving memory - prepare present speech `` virtual audience '' use virtual reality goggles - undergo functional magnetic resonance imaging ( fMRI ) perform task involve look picture , remember thing , test reaction time , make simple choice Those improved end study offer standard antianxiety medication treatment 1 3 month . If participant wish take medication , study clinician help him/her locate psychological care community . Participants ask complete follow-up assessment 3 month last CBT session .</brief_summary>
	<brief_title>Use Antibiotic Enhancer Treatment Social Phobia</brief_title>
	<detailed_description>Social phobia afflict 3 % -15 % US population . As , particularly common debilitate psychiatric disorder . Like many anxiety disorder , social phobia typically arise adolescence . Treatment consist medication cognitive behavioral therapy ( CBT ) . Selective Serotonin Reuptake Inhibitors ( SSRIs ) represent first-line pharmacological treatment adult well adolescent ( APA Treatment Guidelines 2004 ) . Similarly , CBT significantly improve outcome age group . This treatment consist psychoeducation , exposure therapy , cognitive restructuring . While treatment produce clinically meaningful benefit , patient exhibit positive response treatment continue exhibit mark residual symptom , full-blown anxiety disorder . Thus , great need treatment advance . Intense fear social scrutiny represent core component social phobia , extinction fear represent goal exposure therapy CBT ( Cohn Hope ) . Finding treatment facilitate extinction paramount importance . In animal , extinction involve active learn process block glutamatergic NMDA antagonist facilitate NMDA agonist . Specifically , administration D-cycloserine ( DCS ) , partial agonist glycine modulatory site NMDA receptor , produce dose-dependent facilitation extinction rat . As , DCS might facilitate extinction exposure-based CBT . Indeed , Ressler ( Ressler et al 2004 ) recently report preliminary data clinical trial support hypothesis . We examine degree DCS treatment augment clinical response social phobia CBT-exposure-based therapy . Specifically , study two group individual social phobia , receive CBT . One group receive placebo ; second group receive 50 mg D-cycloserine 1-2 hour exposure therapy session . We hypothesize compare placebo , DCS produce great reduction social anxiety symptom follow CBT treatment . Finally , give chronic social anxiety disorder virtually always begin childhood , particularly vital develop early intervention disorder . Accordingly , trial examine adolescent adults disorder .</detailed_description>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Subjects 8 yrs age ( preadolescents ) 55 yrs age . 2 . Subjects medically healthy . 3 . Able give inform consent . 4 . Not psychotropic med minimum 6 week fluoxetine ; minimum 1 week PRN benzodiazepine beta blocker , minimum 3 week psychotropic med . 5 . Subjects diagnose DSM IV symptoms social phobia , generalize specific type . EXCLUSION CRITERIA : 1 . Current major depressive disorder . 2 . Lifetime diagnosis psychotic disorder , bipolar disorder , eat disorder , mental retardation , substance alcohol dependence ( nicotine ) ; active suicidal ideation . 3 . Current lifetime history neurological disorder ( tic disorder , febrile seizure infancy ) , seizure disorder . 4 . Any unstable medical condition . 5 . Use psychoactive substance past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Cognitive</keyword>
	<keyword>Behavioral</keyword>
	<keyword>Adolescent</keyword>
	<keyword>Therapy</keyword>
	<keyword>Extinction</keyword>
	<keyword>Social Phobia</keyword>
</DOC>